SCHEMBL1347585

SCHEMBL1347585

CN(Cc1ccc(-c2cccc(C(N)=O)c2)nc1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HPGDS O60760 1/20 0.41
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FYN P06241 7/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
HSD11B1 P28845 1/20 0.38
TRPV1 Q8NER1 2/20 0.37
MGLL Q99685 1/20 0.37
SCN9A Q15858 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347759 0.79 KDM1A (0.52) KDM1ACYP11B1CYP11B2HPGDSFYN
SCHEMBL1347586 0.78 KDM1A (0.51) KDM1ACYP11B1CYP11B2HPGDSSIRT2
SCHEMBL1347739 0.76 KDM1A (0.48) KDM1ACYP11B1CYP11B2HPGDSFYN
SCHEMBL424646 0.71 USP2 (0.43) KDM1ACYP11B2USP2TP53ALOX15
SCHEMBL12133483 0.70 KDM1A (0.50) KDM1ACYP11B1CYP11B2HPGDSTP53
SCHEMBL1347747 0.70 KDM1A (0.51) KDM1ACYP11B1CYP11B2HPGDSFYN
SCHEMBL1345620 0.69 OPRM1 (0.49) KDM1ACYP11B1CYP11B2HPGDSMAPK1
SCHEMBL1348274 0.69 KDM1A (0.49) KDM1ACYP11B1CYP11B2HPGDSFYN
SCHEMBL2485266 0.68 KDM1A (0.59) KDM1ACYP11B1CYP11B2HPGDSFYN
SCHEMBL13929437 0.68 KDM1A (0.44) KDM1ACYP11B1CYP11B2HPGDSFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US claimed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 KDM1A 2408/4885CYP11B1 195/4885CYP11B2 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.